| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.84B | 40.99B | 38.37B | 28.05B | 26.71B | 19.66B |
| Gross Profit | 8.13B | 7.79B | 7.14B | 5.18B | 4.71B | 3.80B |
| EBITDA | 4.29B | 3.98B | 6.05B | 3.33B | 2.74B | 1.64B |
| Net Income | 2.23B | 2.02B | 3.75B | 1.94B | 1.55B | 772.00M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 37.06B | 31.95B | 24.93B | 20.46B | 20.61B |
| Cash, Cash Equivalents and Short-Term Investments | 9.64B | 9.98B | 7.80B | 4.25B | 4.33B | 4.18B |
| Total Debt | 0.00 | 761.32M | 1.05B | 577.98M | 539.28M | 677.24M |
| Total Liabilities | -17.98B | 19.07B | 15.95B | 12.65B | 10.11B | 11.82B |
| Stockholders Equity | 17.98B | 17.98B | 16.00B | 12.28B | 10.35B | 8.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.71B | 1.43B | 1.95B | 376.66M | 2.23B |
| Operating Cash Flow | 0.00 | 3.59B | 2.57B | 3.01B | 657.49M | 2.59B |
| Investing Cash Flow | 0.00 | -3.23B | -3.10B | -1.66B | -1.01B | -478.63M |
| Financing Cash Flow | 0.00 | -524.36M | 207.16M | -160.50M | -441.90M | -507.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹45.52B | 3.29 | ― | ― | -17.28% | 43.34% | |
68 Neutral | ₹61.78B | 23.52 | ― | 0.06% | 5.56% | -22.59% | |
67 Neutral | ₹43.50B | 10.66 | ― | 0.67% | 13.96% | 12.91% | |
67 Neutral | ₹35.35B | 17.56 | ― | ― | -15.09% | -15.98% | |
64 Neutral | ₹20.57B | 10.29 | ― | ― | 15.23% | 8.61% | |
60 Neutral | ₹4.62B | 7.50 | ― | 0.47% | -7.32% | -26.92% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |
Ahluwalia Contracts (India) Limited has announced the closure of its trading window for company insiders, including directors, officers, designated employees and certain connected persons such as auditors, law firms, analysts and consultants, from 1 January 2026 until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. Trading in the company’s securities will continue to remain open for general investors, and the board meeting date to approve these financial results will be communicated separately, underscoring the firm’s adherence to SEBI’s insider trading regulations and its internal code of conduct to ensure fair disclosure and prevent unlawful trading ahead of key financial announcements.